Switch to:
Array BioPharma Inc (NAS:ARRY)
EV/EBITDA
120.12 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Array BioPharma Inc's enterprise value is $921.69 Mil. Array BioPharma Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $7.67 Mil. Therefore, Array BioPharma Inc's EV/EBITDA ratio for today is 120.12.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Array BioPharma Inc's stock price is $6.80. Array BioPharma Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-0.12. Therefore, Array BioPharma Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Array BioPharma Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=921.685/7.673
=120.12

Array BioPharma Inc's current Enterprise Value is $921.69 Mil.
Array BioPharma Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -24.837 (Jun. 2014 ) + -24.208 (Sep. 2014 ) + -5.137 (Dec. 2014 ) + 61.855 (Mar. 2015 ) = $7.67 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Array BioPharma Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=6.80/-0.123
=

Array BioPharma Inc's share price for today is $6.80.
Array BioPharma Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -0.223 (Jun. 2014 ) + -0.21 (Sep. 2014 ) + -0.06 (Dec. 2014 ) + 0.37 (Mar. 2015 ) = $-0.12.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14
ev2ebitda -9.61-8.55-7.71-2.12-1.74-2.95-5.58-48.01-11.25-8.36

Array BioPharma Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda -17.67-15.66-11.25-14.39-10.75-9.74-8.36-5.60-7.81124.19
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK